Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Establishes Grant Program to Fund microRNA Research

Premium

Exiqon this week said that it has set aside seed funding of $40,000 to support projects from researchers at academic and non-profit institutions.

According to Copenhagen, Denmark-based Exiqon, awards will be given to researchers who aim to understand how microRNA expression and function relates to normal cellular development and disease-related cellular pathways.

Recipients can use awards for the purchase of any Exiqon microRNA offering, including microarrays, as well as quantitative RT-PCR analysis, Northern blotting, in situ hybridization, and knockdown studies. Exiqon also offers microRNA profiling services for microarray and qRT-PCR analysis, the firm said.

Applications for the program are due no later than Feb. 28 and can be filed electronically here. Grant recipients will be announced on or about March 15.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.